# Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography

Study · id `cardio:ct-nct02103959` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02103959](<https://clinicaltrials.gov/study/NCT02103959>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02103959

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 361 participants.

## Technical summary

Registry record NCT02103959. Randomized; quadruple masking; primary purpose prevention. Start 2014-06 (registry gives no type); primary completion 2015-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 361 participants (enrolled count; ClinicalTrials.gov record NCT02103959, source copy `cardio:ctgov-nct02103959-2016-02-23`, retrieved 2026-10-26)
- Start date: 2014-06 (registry gives no type) (ClinicalTrials.gov record NCT02103959, source copy `cardio:ctgov-nct02103959-2016-02-23`, retrieved 2026-10-26)
- Primary completion: 2015-09 (actual) (ClinicalTrials.gov record NCT02103959, source copy `cardio:ctgov-nct02103959-2016-02-23`, retrieved 2026-10-26)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02103959, source copy `cardio:ctgov-nct02103959-2016-02-23`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02103959-2016-02-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of CMX-2043 for Protection of the Heart and Kidneys in Subjects Undergoing Coronary Angiography
- Acronym: CARIN
- Condition: Non STEMI
- Condition: Unstable Angina
- Intervention (Drug): CMX-2043
- Intervention (Drug): Placebo comparator
- Lead sponsor: Ischemix, LLC
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Non-ST-elevation heart attack (NSTEMI) (`cardio:nstemi`)
- Registry condition terms include this condition: Unstable angina (`cardio:unstable-angina`)

## Provenance

Content hash: aa064529ab8421c526658a2f079391830b8315ad7b451b8879f96cbe36fe11c0
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
